Oftentimes, patients with complex skin cancers are seen by multiple physicians in different locations. Scheduling difficulties with these physicians could delay start of treatment. To solve this problem, the Arizona Cancer Center's Skin Cancer Multidisciplinary Clinic was formed.
The clinic includes General Dermatology as well as the Arizona Cancer Center's Cutaneous Oncology Program (COP) and the Pigmented Lesion Clinic (PLC). The Skin Cancer Multidisciplinary Clinic is a model for providing comprehensive skin cancer management.
Go to the Skin Cancer Multidisciplinary Clinic.
The unique aspects of the Skin Cancer Multidisciplinary Clinic are:
- A multidisciplinary team of experts
These experts use a team approach to patient assessment, treatment and management, all occurring in a state-of-the-art facility. Team members work closely with referring physicians to create a plan of care and follow-up for individual patients.
- Centralized resources for diagnosis, treatment, referral, support and education
- Specialized clinics in the Cutaneous Oncology Clinic focused on melanoma and nonmelanoma skin cancers
A total of approximately 1,400 new cases of melanoma are expected to be diagnosed in Arizona during 2013. Up to 55% of cases will potentially require multidisciplinary care that includes surgical oncology, medical oncology, and/or dermato-oncology evaluations.
- Pigmented Lesion Clinic for melanoma surveillance and management of high-risk individuals with atypical moles
Over 300 high-risk patients are currently participating in this specialized clinic.
- One-on-one patient education for individuals at high risk for skin cancer
Over 1,200 patients have been counseled since the education program began in 2006.
To learn more about the patient education activities at the Skin Cancer Institute, contact Lisa Quale at (520) 626-1074 or toll free at 888-724-2749. If you are a physician working in the Tucson area, we can work with you to develop patient education materials for your practice.
- Customized patient care with options in standard therapies and clinical trials